IntRon Biotechnology to issue stocks for US$23.7m capital increase

Published : Jul 5, 2016 - 17:07 Updated : Jul 5, 2016 - 17:07

◀ Back to List
More article by this Writer

[DISCLOSURE] IntRon Biotechnology (048530) has decided on a 27.2 billion won (US$23.7 million) capital increase with third party allotment to secure fund for R&D. The company will issue 15 million shares at 500 won each.

◀ Back to List
More article by this Writer

LATEST NEWS

>

[From the Scene] Immersive heritage exhibition opens in Gangneung, Las Vegas
>

Opposition leader faces sentencing hearing over allegedly suborning perjury this week
>

Japan voices regret over S. Korea's non-attendance of Sado memorial
>

S. Korea not to attend Sado mine memorial: foreign ministry
>

[Weekender] Korea's traditional sauce culture gains global recognition
>

[What to Play] Cozy songs to warm you up
>

Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
>

Gyeongju blends old with new
>

At Gwangcheonok, try North Korean-style sundae gukbap
>

Over 80,000 malicious calls made to Seoul call center since 2020